Radioligand therapy delivers radiation to prostate cancer cells that express a protein called prostate-specific membrane antigen (PSMA) that delayed worsening on scans or death, but increased side effects, including severe adverse events and dry mouth.
C. Buonerba, G. Di Lorenzo· Current Oncology· 0 citations
Receptor-based bioassays measure mixture activity whose relationship with human physiology requires empirical assessment. We examined plasma polycyclic aromatic hydrocarbon (PAH)-like aryl hydrocarbon receptor bioactivity in the selected cross-sectional SPES biomonitoring substudy in Campania, Italy. Out of 598 assay r...
P. Cerino, Elvira De Rosa, Maria Triassi et al.· International Journal of Mol...· 0 citations
Background and Objectives: SPES was a 2016–2017 regional biomonitoring program. We conducted a secondary cross-sectional analysis of associations between current serum trace-element distributions and heterogeneous, self-reported physician-diagnosed tumor history, rather than registry-confirmed or incident cancer. Mater...
C. Buonerba, P. Montuori, E. Esposito et al.· Medicina· 1 citation
Low-density lipoprotein cholesterol and neutrophil-to-lymphocyte ratio were co-primary outcomes; systemic immune–inflammation index (SII) was secondary; Adjusted models used multiple imputation and false-discovery-rate (FDR) correction.
C. Buonerba, P. Montuori, E. Esposito et al.· Toxics· 2 citations
Background: SPES links municipal-cluster biomonitoring with questionnaire data in Campania. We evaluated associations between food-frequency questionnaire (FFQ)-derived food-source patterns, water intake, and serum trace-element biomarkers. Methods: This cross-sectional analysis included 4137 diet responders. Fifteen f...
Annachiara Coppola, P. Montuori, Maria Triassi et al.· Journal of Xenobiotics· 2 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.